The Frequency of HIV-1 Infection in Iranian Children and Determination of the Transmitted Drug Resistance in Treatment-naïve Children.
暂无分享,去创建一个
H. Keyvani | F. Bokharaei-Salim | M. Esghaei | Arezoo Marjani | S. Monavari | S. J. Kiani | A. Ataei-pirkooh | Maryam Jarchi | Fatemeh Jahanbakhshi | A. Ataei-Pirkooh | Maryam Esghaei
[1] H. Miot,et al. Depression and Coping Are Associated with Failure of Adherence to Antiretroviral Therapy Among People Living with HIV/AIDS. , 2019, AIDS research and human retroviruses.
[2] Stephen A. Rawlings,et al. Successful optimization of antiretroviral regimens in treatment‐experienced people living with HIV undergoing liver transplantation , 2019, Transplant infectious disease : an official journal of the Transplantation Society.
[3] Ingrid A. Beck,et al. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study , 2019, PloS one.
[4] W. MacLeod,et al. Adolescent HIV treatment in South Africa's national HIV programme: a retrospective cohort study. , 2019, The lancet. HIV.
[5] C. Tremblay,et al. Association between lipodystrophy and length of exposure to ARTs in adult HIV-1 infected patients in Montreal , 2019, BMC Infectious Diseases.
[6] M. Hughes,et al. Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study. , 2019, The lancet. HIV.
[7] E. Arts,et al. The urgent need for more potent antiretroviral therapy in low-income countries to achieve UNAIDS 90-90-90 and complete eradication of AIDS by 2030 , 2019, Infectious Diseases of Poverty.
[8] A. Memarnejadian,et al. HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of Iran , 2019, Intervirology.
[9] V. Calvez,et al. Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali. , 2019, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[10] M. Lampe,et al. Epidemiology of Perinatal HIV Transmission in the United States in the Era of Its Elimination. , 2019, The Pediatric infectious disease journal.
[11] M. Mohraz,et al. Evaluation of Acquired HIV Drug Resistance among People Living with HIV Who Have Taken Antiretroviral Therapy for 9–15 Months in 14 Triangular Clinics in Iran, 2015–2016 , 2019, Intervirology.
[12] P. Victor,et al. Performance of a Modified In-house HIV-1 Avidity Assay among a Cohort of Newly Diagnosed HIV-1 Infected Individuals and the Effect of ART on Maturation of HIV-1 Specific Antibodies. , 2019, Current HIV research.
[13] H. Xing,et al. HIV Epidemiology and Prevention in Southwestern China: Trends from 1996-2017 , 2018, Current HIV Research.
[14] A. Boyko,et al. Molecular Surveillance of HIV-1 infection in Krasnoyarsk Region, Russia: Epidemiology, Phylodynamics and Phylogeography. , 2019, Current HIV research.
[15] H. Keyvani,et al. Investigation of the effects of a prevention of mother-to-child HIV transmission program among Iranian neonates , 2018, Archives of Virology.
[16] M. Lampe,et al. Brief Report: Estimated Incidence of Perinatally Acquired HIV Infection in the United States, 1978–2013 , 2017, Journal of acquired immune deficiency syndromes.
[17] Á. Holguín,et al. Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis , 2017, The Pediatric infectious disease journal.
[18] R. Shirkoohi,et al. Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran , 2017, Iranian journal of public health.
[19] W. Mcfarland,et al. The First Characterization of HIV-1 Subtypes and Drug Resistance Mutations among Antiretrovirally Treated Patients in Kermanshah, Iran , 2017, Intervirology.
[20] A. Borkhardt,et al. HIV-1 Subtype Diversity and Prevalence of Primary Drug Resistance in a Single-Center Pediatric Cohort in Germany , 2017, Intervirology.
[21] R. Njouom,et al. HIV Drug Resistance Testing in a Resource Limited Setting with High Viral Diversity: The First Twenty Eight Months Experience. , 2017, Current HIV research.
[22] R. Shafer,et al. HIV-1 drug resistance and resistance testing. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[23] S. Khazaei,et al. Challenges and Proposed Actions for HIV/AIDS Control among Children in Iran , 2016 .
[24] H. Keyvani,et al. Assessment of the Human Cytomegalovirus UL97 Gene for Identification of Resistance to Ganciclovir in Iranian Immunosuppressed Patients , 2016, Jundishapur journal of microbiology.
[25] G. M. Souza,et al. Transmitted Drug Resistance Among Recently Diagnosed Adults and Children in São Paulo, Brazil. , 2015 .
[26] S. Rowland-Jones,et al. Outcomes of prevention of mother to child transmission of the human immunodeficiency virus-1 in rural Kenya—a cohort study , 2015, BMC Public Health.
[27] M. Mohraz,et al. Pregnancy through the Lens of Iranian Women with HIV , 2015, Journal of the International Association of Providers of AIDS Care.
[28] D. Katzenstein,et al. Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] G. Shanmugam,et al. Prediction of drug-resistance using genotypic and docking analysis among anti-retroviral therapy naïve and first-line treatment failures in Salem, Tamil Nadu, India. , 2015, Current HIV research.
[30] S. Kabra,et al. Mutations in the Reverse Transcriptase and Protease Genes of Human Immunodeficiency Virus-1 from Antiretroviral Naïve and Treated Pediatric Patients , 2015, Viruses.
[31] R. Kantor,et al. Antiretroviral treatment failure, drug resistance, and subtype diversity in the only pediatric HIV clinic in Rhode Island. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] P. Easterbrook,et al. Assessment of second-line antiretroviral regimens for HIV therapy in Africa. , 2014, The New England journal of medicine.
[33] P. Frange,et al. Missed Opportunities for HIV Testing in Pregnant Women and Children Living in France , 2014, The Pediatric infectious disease journal.
[34] W. Adebimpe,et al. Perception on prevention of mother-to-child-transmission (PMTCT) of HIV among women of reproductive age group in Osogbo, Southwestern Nigeria , 2013, International journal of women's health.
[35] A. Kamarulzaman. Fighting the HIV epidemic in the Islamic world , 2013, The Lancet.
[36] H. Joulaei,et al. Primary Health Care Strategic Key to Control HIV/AIDS in Iran , 2013, Iranian journal of public health.
[37] H. Keyvani,et al. Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011 , 2013, PloS one.
[38] F. Ceccherini‐Silberstein,et al. Emerging patterns and implications of HIV-1 integrase inhibitor resistance , 2012, Current opinion in infectious diseases.
[39] V. Sreenivas,et al. Prevalence of HIV drug resistance mutation in the northern Indian population after failure of the first line antiretroviral therapy. , 2012, Current HIV research.
[40] Suharni Mohamad,et al. Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia. , 2012, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[41] Tommy F. Liu,et al. Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Analysis Tool , 2012, Journal of Clinical Microbiology.
[42] R. Mehrdad,et al. Survey of Human Immunodeficiency Virus-1 Protease Gene Drug Resistance among HIV-infected Patients in an Iranian Research Center for HIV/AIDS , 2012 .
[43] D. Harris,et al. HIV Drug Resistance-Associated Mutations in Antiretroviral Naïve HIV-1-Infected Latin American Children , 2011, Advances in virology.
[44] C. Diazgranados,et al. Antiretroviral drug resistance in HIV-infected patients in Colombia. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[45] Zeraati Hojjat,et al. Preventing Mother-to-Child Transmission of HIV/AIDS: Do Iranian Pregnant Mothers Know about it? , 2010, Journal of reproduction & infertility.
[46] S. Crowe,et al. Stability of dried blood spots for HIV-1 drug resistance analysis. , 2010, Current HIV research.
[47] J. Pinto,et al. Prevalence of primary drug resistance-associated mutations among HIV type 1 vertically Infected children in Belo Horizonte, Brazil. , 2010, AIDS research and human retroviruses.
[48] O. Abidi,et al. The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco. , 2009, Journal of infection in developing countries.
[49] Anne-Mieke Vandamme,et al. Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update , 2009, PloS one.
[50] S. Hammer,et al. Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] S. Sehgal,et al. High rate of mutation K103N causing resistance to nevirapine in Indian children with acquired immunodeficiency syndrome. , 2008, Indian journal of medical microbiology.
[52] Amalio Telenti,et al. Antiretroviral Treatment of Adult HIV Infection2010 Recommendations of the International AIDS Society–USA Panel , 2010 .
[53] D. Bennett,et al. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites , 2008, Antiviral therapy.
[54] M. Hughes,et al. Neurodevelopmental Functioning in HIV-Infected Infants and Young Children Before and After the Introduction of Protease Inhibitor–Based Highly Active Antiretroviral Therapy , 2007, Pediatrics.
[55] J. Lindsey,et al. Growth of Human Immunodeficiency Virus-Infected Children Receiving Highly Active Antiretroviral Therapy , 2005, The Pediatric infectious disease journal.
[56] J. Temple,et al. Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. , 2004, Journal of virological methods.
[57] Thorvaldur Gylfason,et al. Natural resources, education, and economic development , 2000 .
[58] Christos J. Petropoulos,et al. A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1 , 2000, Antimicrobial Agents and Chemotherapy.
[59] L. Kalish,et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. , 1997, The New England journal of medicine.
[60] B. Korber,et al. Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease , 1997, Journal of virology.
[61] K. Mcintosh,et al. Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus. , 1996, The Pediatric infectious disease journal.
[62] B. Larder,et al. Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase. , 1994, The Journal of general virology.
[63] Qinggang Xu,et al. Genotypic Methods for HIV Drug Resistance Monitoring: the Opportunities and Challenges Faced by China. , 2019, Current HIV research.
[64] M. Garcia-deltoro. Rapid Initiation of Antiretroviral Therapy after HIV Diagnosis. , 2019, AIDS reviews.
[65] M. Aghasadeghi,et al. Comparison of antiretroviral drug resistance among treatment-naive and treated HIV-infected individuals in Shiraz, Iran , 2017, Archives of Virology.
[66] A. Memarnejadian,et al. Prevalence of HIV-1 pre-treatment drug resistance in a southern province of Iran, 2016-2017 , 2017, Archives of Virology.
[67] Huldrych F. Günthard,et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. , 2012, JAMA.
[68] A. Meynard,et al. Developing youth friendly primary care services in Bosnia & Herzegovina. , 2009 .
[69] A. Tafti,et al. Knowledge and attitude about HIV/AIDS among pregnant women in Yazd, Iran , 2006 .